Pfizer (PFE) stock in focus as company faces lawsuits over its alleged failure to warn about brain tumor risks linked to Depo ...

A well-known injectable birth control method is under fire after multiple studies linked it to a specific kind of brain tumor, and now, lawsuits are piling up against the drugmaker. […] The post ...

Pfizer settles over 10,000 Zantac-related cancer lawsuits, marking a significant legal agreement amidst concerns over NDMA contamination in the popular heartburn medication.

Wall Street ended higher on Friday, capping off a strong week that saw both the Nasdaq Composite and S&P 500 finish the week ...

A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac.

Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.

Big Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over allegations that the company failed to warn people about possible cancer risks caused by their ...

Pfizer settles 10,000 Zantac lawsuits over cancer risks, but challenges remain. Details undisclosed. Sanofi's $100 million+ agreement also noted. Legal battles ongoing.

GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link By Brendan Pierson December 6, 20223:41 PM PSTUpdated December 6, 2022 ...

S everal big drugmakers — Sanofi, GSK, Pfizer and Boehringer Ingelheim — will not have to face thousands of lawsuits claiming the Zantac heartburn drug can cause cancer after a federal judge ...

Pfizer was hit with a consumer class action Tuesday in Florida Southern District Court over the company's generic version of the anti-smoking drug Chantix. The lawsuit, filed by Rivero Mestre LLP ...